Skip to main content
. 2020 Nov 12;21(1):33. doi: 10.3892/ol.2020.12294

Figure 2.

Figure 2.

Clinical significance of miR-4636 in the diagnosis and prognosis of GC. (A) A receiver operating characteristics curve based on serum miR-4636 levels of patients with GC (AUC, 0.963). (B) The Kaplan-Meier overall survival curves for patients with GC and different expression patterns of miR-4636 (log-rank, P<0.001). (C) The disease-free survival curves for patients with GC with high or low miR-4636 expression (log-rank, P=0.006). miR, microRNA; GC, gastric cancer; AUC, area under the curve.